Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review
- PMID: 24661645
- PMCID: PMC3987838
- DOI: 10.1186/1756-0500-7-171
Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is an incurable motor neuron degenerative disease which onset and course may be affected by concurrent diabetes mellitus (DM). We performed a systematic review to assess the effect of DM/dysglycemic states on ALS.
Methods: We searched PubMed MEDLINE, from inception to March 2013 for original articles published in English and in French languages on DM (and related states) and ALS. We made no restriction per study designs.
Results: Seven studies/1410 citations (5 case-control and 2 cross-sectional) were included in the final selection. The number of participants with ALS ranged from 18 to 2371. The outcome of interest was ALS and DM/dysglycemic states respectively in three and two case control-studies. DM/impaired glucose tolerance status did not affect disease progression, survival, disease severity and disease duration in ALS participants but ALS participants with DM were found to be older in one study. DM/IGT prevalence was similar in both ALS and non ALS participants. This review was limited by the absence of prospective cohort studies and the heterogeneity in ALS and DM diagnosis criteria.
Conclusions: This systematic review suggests that evidences for the association of ALS and DM are rather limited and derived from cross-sectional studies. Prospective studies supplemented by ALS registries and animal studies are needed to better understand the relationship between both conditions.
Figures
Similar articles
-
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4. Cochrane Database Syst Rev. 2017. PMID: 28982219 Free PMC article.
-
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2013 Mar 28;(3):CD004427. doi: 10.1002/14651858.CD004427.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Oct 06;10:CD004427. doi: 10.1002/14651858.CD004427.pub4. PMID: 23543531 Updated.
-
Interventions for fatigue and weight loss in adults with advanced progressive illness.Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Apr 07;4:CD008427. doi: 10.1002/14651858.CD008427.pub3. PMID: 22258985 Updated.
-
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD006049. doi: 10.1002/14651858.CD006049.pub2. Cochrane Database Syst Rev. 2017. PMID: 28067943 Free PMC article.
-
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article.
Cited by
-
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2061-71. doi: 10.1007/s00259-016-3440-3. Epub 2016 Jul 15. Eur J Nucl Med Mol Imaging. 2016. PMID: 27421971 Free PMC article. Clinical Trial.
-
Association between diabetes and amyotrophic lateral sclerosis in Sweden.Eur J Neurol. 2015 Nov;22(11):1436-42. doi: 10.1111/ene.12632. Epub 2015 Jan 19. Eur J Neurol. 2015. PMID: 25600257 Free PMC article.
-
Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.BMC Med. 2019 Dec 4;17(1):225. doi: 10.1186/s12916-019-1448-9. BMC Med. 2019. PMID: 31796040 Free PMC article.
-
PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.Hum Mol Genet. 2015 Mar 15;24(6):1741-54. doi: 10.1093/hmg/ddu587. Epub 2014 Nov 28. Hum Mol Genet. 2015. PMID: 25432537 Free PMC article.
-
Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study.J Epidemiol. 2015;25(6):445-51. doi: 10.2188/jea.JE20140176. Epub 2015 May 2. J Epidemiol. 2015. PMID: 25947580 Free PMC article.
References
-
- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. doi: 10.1016/S0140-6736(11)60679-X. - DOI - PubMed
-
- Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev. 1999;7:245–252.
-
- Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P. Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293. doi: 10.2337/dc10-1303. - DOI - PMC - PubMed
-
- Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12(3):310–322. doi: 10.1016/S1474-4422(13)70036-X. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous